Medindia LOGIN REGISTER
Medindia

Second Bivalent COVID-19 Booster Targeting Omicron Variants Approved

by Colleen Fleiss on Nov 4 2022 11:22 PM
Listen to this article
0:00/0:00

Health Canada approved the bivalent COVID-19 vaccine for use as a booster dose in individuals 18 years of age or older,

Second Bivalent COVID-19 Booster Targeting Omicron Variants Approved
An adapted version of the Moderna Spikevax COVID-19 vaccine that targets the Omicron BA.4/BA.5 sub-variants has been approved by Health Canada.

Bivalent COVID-19 Booster

This adapted vaccine has a similar safety profile to the previously approved Moderna Spikevax boosters, with the same mild adverse reactions that resolved quickly, Health Canada said.
Keeping COVID-19 vaccinations up-to-date, including getting booster doses as recommended, will help protect an individual against serious illness and other complications of the infection, Health Canada said.

The number of total COVID-19 cases and deaths have now reached 4,336,860 and 46,389, respectively, according to the weekly update issued by the Public Health Agency of Canada.

According to the agency, the cumulative people who had received at least one dose of a COVID-19 vaccine in Canada was 83 percent.

However, those who had in the last six months completed the primary series or received a booster dose with a COVID-19 vaccine in Canada was only 17.2 percent.

Source-IANS


Advertisement